AI assistant
Morgan Advanced Materials PLC — Remuneration Information 2018
Aug 1, 2018
4597_dirs_2018-08-01_2dbc60ff-cb3a-43f1-be85-5d30befd8dbe.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 4477W
Morgan Advanced Materials PLC
01 August 2018
1
Details of the person discharging managerial responsibilities / persons closely associated
a)
Name
Paul Boulton
2
Reason for the notification
a)
Position/status
PDMR - General Counsel
b)
Initial notification/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Morgan Advanced Materials plc
b)
LEI
I4K14LL95N2PHDL7EG85
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 25p each
GB0006027295
b)
Nature of the transaction
A proportion of the participant's bonus earned in 2014 was deferred into an award of shares under the Bonus Deferral Share Matching Plan (BDSMP) in March 2015. The Deferred Award vested on 23 March 2018. Participants have six months following vesting to call on the vested Deferred Shares.
c)
Price(s) and volume(s)
| No. of shares acquired | No. of shares sold | Sale price per share | No. of shares retained |
| 19,041 | 19,041 | GBP 3.5620 | NIL |
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
2018-07-31
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLIFEDTVILIIT